Insider Shareholders with Direct Ownership of Fulcrum Therapeutics, Inc. (FULC)
This section provides a comprehensive overview of the insiders with direct ownership of Fulcrum Therapeutics, Inc. (FULC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Fulcrum Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Third Rock Ventures Iv, L.P.
> 10% Shareholder |
2,343,154 | 0 | 2,343,154 $7.52 Million | 1 |
Jul 22, 2019
Added 3.35%
|
|
Third Rock Ventures Iii, L.P.
> 10% Shareholder |
5,676,488 | 4,000,000 | 1,962,202 $6.3 Million | 4 |
Dec 13, 2022
Reduced 50.48%
|
| 237,939 | 272,920 | 499,864 $1.6 Million | 21 |
Jan 13, 2023
Reduced 1.34%
|
|
| 193,360 | 0 | 193,360 $620,685 | 2 |
Jul 03, 2024
Added 43.69%
|
|
| 10,000 | 0 | 90,714 $291,191 | 1 |
Jun 28, 2021
Added 9.93%
|
|
|
Peter G. Thomson
VP Finance & Accounting |
5,000 | 11,607 | 15,212 $48,830 | 3 |
Feb 22, 2021
Reduced 24.74%
|
|
Greg Tourangeau
Principal Accounting Officer |
3,250 | 5,330 | 11,571 $37,142 | 4 |
May 07, 2024
Reduced 2.0%
|
|
Christopher Morabito
Chief Medical Officer |
1,100 | 0 | 1,100 $3,531 | 1 |
Jun 28, 2021
Added 50.0%
|
|
Curtis Gale Oltmans
Chief Legal Officer |
1,088 | 0 | 1,088 $3,492 | 1 |
Jun 28, 2021
Added 50.0%
|
|
Bryan Stuart
Director |
60,000 | 60,000 | 0 $0 | 4 |
Aug 11, 2021
Reduced 100.0%
|
|
Christopher Moxham
Chief Scientific Officer |
51,785 | 51,785 | 0 $0 | 2 |
Aug 10, 2021
Reduced 100.0%
|